Co-Diagnostics, Inc.

( )
CODX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
IMMUImmunomedics, Inc. -0.32%85.2511.0%$715.31m
MRNAModerna, Inc. -0.04%70.520.0%$666.35m
AMGNAmgen, Inc. 0.51%248.301.3%$659.17m
ILMNIllumina, Inc. 0.01%305.503.5%$626.58m
NVAXNovavax, Inc. -2.91%107.9596.5%$605.28m
GILDGilead Sciences, Inc. -1.19%62.101.0%$578.27m
REGNRegeneron Pharmaceuticals, Inc. 0.30%573.612.7%$438.99m
BIIBBiogen, Inc. 0.11%282.351.6%$350.80m
VRTXVertex Pharmaceuticals, Inc. 0.96%270.311.9%$346.01m
SRNESorrento Therapeutics, Inc. 14.29%11.601.5%$320.77m
ALXNAlexion Pharmaceuticals, Inc. -0.74%112.462.0%$279.94m
EXASEXACT Sciences Corp. 2.32%102.0120.7%$271.56m
SGENSeattle Genetics, Inc. 0.24%190.966.0%$227.45m
VXRTVaxart, Inc. -2.50%6.830.0%$197.82m
MNTAMomenta Pharmaceuticals, Inc. 0.06%52.493.0%$177.06m

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.